Skip to main content

Day: September 30, 2020

O-I Announces Third Quarter 2020 Earnings Conference Call and Webcast

PERRYSBURG, Ohio, Sept. 30, 2020 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASEO-I Glass, Inc. (NYSE: OI) has scheduled its third quarter 2020 conference call and webcast for Wednesday, Oct. 28, 2020, at 8 a.m. EDT. The Company’s news release for the third quarter 2020 earnings will be issued after the market closes on Tuesday, Oct. 27.What:         O-I Conference Call and WebcastEarnings presentation materials will also be posted on the O-I website, www.o-i.com/investors, when the earnings news release is issued.When:        Wednesday, Oct. 28, 2020, at 8 a.m. EDTWhere:      http://investors.o-i.com/webcasts-presentations?c=88324&p=irol-calendarThe webcast will be archived at www.o-i.com/investors until Oct. 2021. To participate in the event via conference call, dial 1-888-733-1701 (U.S. and Canada) or 706-634-4943 (International)...

Continue reading

QEP Resources Completes Redemption of Its 6.875% Senior Notes Due 2021

DENVER, Sept. 30, 2020 (GLOBE NEWSWIRE) — QEP Resources, Inc. (NYSE:QEP) (QEP or the Company) today announced that it completed its previously announced redemption of its 6.875% Senior Notes due 2021 (the “2021 Notes”) in the aggregate principal amount of $275.3 million. The 2021 Notes were redeemed at a redemption price equal to 102.628% of the principal amount thereof, plus accrued and unpaid interest up to, but not including, September 30, 2020.About QEP Resources, Inc.QEP Resources, Inc. (NYSE: QEP) is an independent crude oil and natural gas exploration and production company focused in two regions of the United States: the Southern Region (primarily in Texas) and the Northern Region (primarily in North Dakota). For more information, visit QEP’s website at: www.qepres.com.

Continue reading

La-Z-Boy Receives 2020 ASCM Award of Excellence for Making an Impact Through the Supply Chain

MONROE, Mich., Sept. 30, 2020 (GLOBE NEWSWIRE) — La-Z-Boy today announced it is the recipient of the 2020 Award of Excellence – Making an Impact from the Association for Supply Chain Management (ASCM), the global leader in supply chain learning, transformation, innovation and leadership. Darrell Edwards, SVP and Chief Operating Officer, will be featured in a LinkedIn Live interview on Tuesday, October 20, at 1:00 p.m. Central.La-Z-Boy received the award for its commitment to record-breaking safety performance, sustainability through environmental health and stewardship, and numerous philanthropic and volunteer initiatives within its communities. The company currently has eight zero-waste-to-landfill-endorsed facilities, 97% of its manufacturing waste is reused or recycled, and water conservation efforts have reduced usage by more...

Continue reading

Axogen, Inc. Appoints Paul G. Thomas to Board of Directors

Healthcare veteran brings 30+ years of medtech experience to Axogen, Inc. Board of DirectorsALACHUA, Fla., Sept. 30, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Paul G. Thomas has been appointed to its Board of Directors, effective September 30, 2020. Thomas will serve on both the Governance, Nominating and Sustainability Committee and the Science and Technology Committee.“Paul is an excellent addition to our board, as he brings more than 30 years of proven medical device and healthcare leadership experience in fast-growing biologic and pharmaceutical companies,” commented Karen Zaderej, chairman, CEO, and president. “We are excited for Paul to join our team, and we are looking...

Continue reading

G1 Therapeutics Announces Chief Executive Officer Succession Plan

– Mark Velleca, M.D., Ph.D., G1’s first Chief Executive Officer, to serve as senior advisor and remain member of the G1 Board of Directors– Jack Bailey to succeed Dr. Velleca as Chief Executive Officer effective January 1, 2021RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a company whose mission is to deliver innovative therapies that improve the lives of people with cancer, today announced that effective January 1, 2021, Mark Velleca, M.D. Ph.D., will transition to the role of senior advisor and continue to serve as a member of the G1 Board of Directors. John (“Jack”) Bailey, a member of the company’s board, has been named as G1’s next Chief Executive Officer.Mr. Bailey has nearly thirty years of commercial pharmaceutical experience and an in-depth understanding...

Continue reading

Bank OZK Announces Date for Third Quarter 2020 Earnings Release and Conference Call

LITTLE ROCK, Ark., Sept. 30, 2020 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) expects to report third quarter 2020 earnings after the market closes on Thursday, October 22, 2020. Management’s comments on the third quarter of 2020 will be released simultaneously with the earnings press release and will be available on the Bank’s investor relations website.   Management will conduct a conference call to take questions at 10:00 a.m. CT (11:00 a.m. ET) on Friday, October 23, 2020. Interested parties may listen to this call by dialing 1-844-818-5110 (U.S. and Canada) or 210-229-8841 (international) and asking for the Bank OZK conference call. A recorded playback of the call will be available for one week following the call at 1-855-859-2056 (U.S. and Canada) or 404-537-3406 (international). The passcode for this playback is...

Continue reading

Landmark Infrastructure Partners LP Announces Completion of Digital Infrastructure Acquisitions

EL SEGUNDO, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — Landmark Infrastructure Partners LP (the “Partnership” or “Landmark”) (NASDAQ: LMRK) announced today that it has acquired data center sites in the greater Toronto, Ontario and Atlanta, Georgia areas from Sungard Availability Services (“Sungard AS”), a leading provider of cloud connected infrastructure solutions. Landmark is leasing the acquired data center sites back to Sungard AS in their entirety, which combined totals approximately 215,000 square feet and approximately 4 megawatts of critical capacity. The acquisitions were funded by borrowings from the Partnership’s existing revolving credit facility and are expected to be immediately accretive to Landmark’s adjusted funds from operations (“AFFO”).“We continue to expand our digital infrastructure footprint with the addition...

Continue reading

LogicBio Therapeutics Announces Proposed Public Offering of Common Stock

LEXINGTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of the offering, LogicBio intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering on the same terms and conditions. All shares being offered are to be sold by LogicBio.Jefferies, Barclays and William Blair are acting as joint book-running managers, and Chardan is acting as lead manager for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the...

Continue reading

Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5

MONTREAL, Sept. 30, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer, will present at the H.C. Wainwright 4th Annual NASH Investor Conference on Monday, October 5, 2020 at 4:30 p.m. ET.A live webcast of his presentation will be accessible at https://journey.ct.events/view/2ae02d3e-4e70-4522-bbba-b3fdb9b57e35. A replay of the webcast will be available one hour after the conclusion of the live event.About TheratechnologiesTheratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs....

Continue reading

Theratechnologies fera une présentation au H.C. Wainwright 4th Annual NASH Investor Conference le 5 octobre 2020

MONTRÉAL, 30 sept. 2020 (GLOBE NEWSWIRE) — Theratechnologies inc. (« Theratechnologies ») (TSX: TH) (NASDAQ: THTX), une société biopharmaceutique commerciale axée sur le développement et la commercialisation de traitements innovateurs, a annoncé aujourd’hui que Dr Christian Marsolais, vice-président principal et chef de la direction médicale, fera une présentation au H.C. Wainwright 4thAnnual NASH Investor Conference le lundi 5 octobre 2020 à 16h30 (heure de l’Est).La présentation de Dr Marsolais sera diffusée en direct par webdiffusion à l’adresse https://journey.ct.events/view/2ae02d3e-4e70-4522-bbba-b3fdb9b57e35. La webdiffusion archivée sera disponible une heure après la fin de l’évènement en direct.À propos de TheratechnologiesTheratechnologies (TSX : TH) (NASDAQ : THTX) est une société biopharmaceutique commerciale axée sur...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.